Differential Pulse Adsorptive Stripping Voltammetric Determination of Zafirlukast in Pharmaceutical Formulations

References

• Adkins , J. C. and Brogden , R. N. 1998 . A review of its pharmacology and therapeutics potential in the management of asthma . Drugs , 55 ( 1 ) : 121 – 144 .
   PubMedGoogle Scholar
• Balzano , G. , Fuschillo , S. and Gaudiosi , C. 2002 . Leukotriene receptor antagonists in the treatment of asthma: an update . Allergy , 57 ( 72 ) : 16 – 19 .
   PubMedGoogle Scholar
• Brabson , J. H. , Clifford , D. , Kerwin , E. , Raphael , G. , Pepsin , J. P. , Edwards , L. D. , Srebro , S. and Rickard , K. 2002 . Efficacy and safety of low‐dose fluticasone propionate compared with zafirlukast in patients with persistent asthma . Am. J. Med. , 113 ( 1 ) : 15 – 21 .
   PubMedGoogle Scholar
• Braggio , S. , Barnaby , R. J. , Grossi , P. and Cugola , M. 1996 . A strategy for validation of bioanalytical methods . J. Pharm. Biomed. Anal. , 14 : 375 – 380 .
   PubMed Web of Science ®Google Scholar
• Bui , K. H. , Coleen , M. K. , Connie , T. A. and Bruce , K. B. 1997 . Determination of zafirlukast, a selective leukotriene antagonist, human plasma by normal‐phase high‐performance liquid chromatography with fluorescence detection . J. Chromatogr. B , 696 ( 1 ) : 131 – 136 .
   PubMedGoogle Scholar
• Calhoun , W. J. 1998 . Summary of clinical trials with zafirlukast . Am. J. Respir. Crit. Care Med. , 157 ( 6 ) : 238 – 245 .
   Google Scholar
• Dunn , C. J. and Goa , K. L. 2001 . Zafirlukast: an update of its pharmacology and therapeutics efficacy in asthma . Drugs , 61 ( 2 ) : 285 – 315 .
   PubMedGoogle Scholar
• Ficarra , R. , Ficarra , P. , Tommasini , S. , Melardi , S. , Calabro , M. L. , Furlanetto , S. and Semreen , M. 2000 . Validation of a LC method for the analysis of zafirlukast in a pharmaceutical formulation . J. Pharm. Biomed. Anal. , 23 ( 1 ) : 169 – 174 .
   PubMedGoogle Scholar
• Finnerty , J. P. , Wood‐Baker , R. , Thomson , H. and Holgate , S. T. 1992 . Role of leukotrienes in exercise‐induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist . Am. Rev. Respir. Dis. , 145 ( 4 ) : 746 – 749 .
   PubMedGoogle Scholar
• Ghoneim , M. M. and Beltagi , A. M. 2003 . Determination of the antibiotic drug pefloxacin in bulk form, tablets and human serum using square wave cathodic adsorptive stripping voltammetry . Talanta , 60 : 911 – 921 .
   PubMedGoogle Scholar
• Ghoneim , M. M. , El‐Baradie , K. Y. and Tawfik , A. 2003 . Electrochemical behavior of the antituberculosis drug isoniazid and its square‐wave adsorptive stripping voltammetric estimation in bulk form, tablets and biological fluids at a mercury electrode . J. Pharm. Biomed. Anal. , 33 : 673 – 685 .
   PubMed Web of Science ®Google Scholar
• Green , J. M. 1996 . A practical guide to analytical method validation . Anal. Chem. , 68 : 305A – 309A .
   Web of Science ®Google Scholar
• Hamam , E. 2002 . Determination of nitrofurantoin drug in pharmaceutical formulation and biological fluids by square‐wave cathodic adsorptive stripping voltammetry . J. Pharm. Biomed. Anal. , 30 : 651 – 659 .
   PubMedGoogle Scholar
• Kaliner , M. , Eggleston , P. A. and Mathews , K. P. 1987 . Rhinitis and asthma . J. Am. Med. Assoc. , 258 : 2851 – 2873 .
   PubMed Web of Science ®Google Scholar
• Kemp , J. P. 2003 . Recent advances in the management of asthma using leukotriene modifiers . Am. J. Respir. Med. , 2 ( 2 ) : 139 – 156 .
   PubMedGoogle Scholar
• Lazarus , S. C. , Lavins , B. J. and Wong , H. H. 1995 . Effect of “Accolate” (zafirlukast) on sulphur dioxide (SO2)–induced bronchoconstriction in patients with bronchial asthma . Am. Rev. J. Respir. Crit. Care Med. , 151 : A41 – A43 .
   PubMedGoogle Scholar
• Lipworth , B. J. 1999 . Leukotriene‐receptor antagonists . Lancet , 353 ( 2 ) : 57 – 62 .
   PubMedGoogle Scholar
• Nathan , R. A. , Bleecker , E. R. and Kalberg , C. 2001 . A comparison of short‐term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma . Am. J. Med. , 111 : 195 – 202 .
   PubMedGoogle Scholar
• Phipatanakul , W. , Eggleston , P. A. , Conover‐Walker , M. K. , Kesavanathan , J. , Sweitzer , D. and Wood , R. 2000 . A randomized, double‐blind, placebo controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge . J. Allergy Clin. Immunol. , 105 ( 4 ) : 704 – 710 .
   PubMed Web of Science ®Google Scholar
• Piatti , G. , Ceriotti , L. , Cavallaro , G. , Ambrosetti , U. , Mantovani , M. , Pistone , A. and Centanni , S. 2003 . Effects of zafirlukast on bronchial asthma and allergic rhinitis . Pharm. Res. Pharm. Res. , 47 ( 6 ) : 541 – 547 .
   PubMedGoogle Scholar
• Radhakrishna , T. , Satyanarayana , J. and Satyanarayana , A. 2002 . Determination of zafirlukast by stability indicating LC and derivative spectrophotometry . J. Pharm. Biomed. Anal. , 30 ( 3 ) : 695 – 703 .
   PubMedGoogle Scholar
• Wang , J. 1985 . 58 – 63 . Dearfield Beach, FL : VCH Publishers .
   Google Scholar
• Wenzel , S. E. 1998 . New approaches to anti‐inflammatory therapy for asthma . Am. J. Med. , 104 ( 3 ) : 287 – 300 .
   PubMedGoogle Scholar